Mirum Pharmaceuticals Profit Margin

The latest profit margin for MIRM is -194.97% as of March 2026. That compares with -20.39% in the prior-year period — down 856.1% year over year. That is below the Healthcare sector average of 15.29%. Investors often review this figure alongside Mirum Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, MIRM's profit margin moved from -20.39% to -194.97% — a 856.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Mirum Pharmaceuticals's valuation or profitability profile.

Against Healthcare companies, MIRM currently prints -194.97% for profit margin, while the sector average sits near 15.29%. That is roughly 1374.9% below the sector mean. Large gaps often invite a closer look at Mirum Pharmaceuticals's growth, margins, and balance sheet.

Profit Margin shows how effectively Mirum Pharmaceuticals converts resources into returns. At -194.97%, MIRM may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -20.39% in the prior-year period — down 856.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting MIRM's profit margin (-194.97%), review year-over-year change from -20.39%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.